The following infographic presents facts and figures collated from a number of surveys and papers.
Click on the videos below to see interviews with Dr Martijn Arns, neuromodulation expert and Global Chief Scientific Advisor for the neuroCare Group.
Watch more videos here
Clinical Indications for rTMS
Dr Arns explains which patients may expect to see results from rTMS (repetitive transcranial magnetic stimulation) treatments, and why rTMS is not currently used for treatment in adolescents, pregnant women, and patients diagnosed with anxiety or psychotic depression.
The Potential Side Effects of rTMS
Dr Arns explains the various contraindications and likelihood of side effects resulting from rTMS treatment.
Typical Response & Remission Rates of rTMS
Dr Arns explains the encouraging efficacy rates of rTMS therapy as indicated by large open-label studies. Further to this, Dr Arns explains why he suspects there may be an enhanced clinical response when rTMS is co-administered with eclectic, personalised psychotherapy when compared to rTMS administration as a monotherapy.
Key Differences Between rTMS and Electroconvulsive Therapy
Dr Arns makes the case for rTMS being considered as the stage before ECT (electroconvulsive therapy) citing the lower side effect rate of rTMS therapy when compared to either ECT or the prescription of SSRIs (selective serotonin reuptake inhibitors).
Key Differences Between High Frequency & Low Frequency rTMS Protocols
Dr Arns talks about the exciting research being conducted with regards to high and low frequency protocols and the new treatment methods which have been recently approved by the American FDA (Food and Drug Administration).
The Principle for Choosing the Dorsolateral Prefrontal Cortex for rTMS
Dr Arns looks into the current state of research and the rationale for preferencing dorsolateral prefrontal cortex stimulation over stimulation of other areas of the brain.
Localising the Exact Point for Maximum Stimulation for rTMS
Dr Arns discusses the current theories behind methods of locating the point of stimulation, and looks at some of the experimental methods used in the United States considering functional connectivity based on MRI (magnetic resonance imaging).
Click on the Scientific Publications link to visit the neuroCare Group website, and read about the scientific research that provides the base for the neuroCare Clinics and their use of neuromodulation and rTMS therapy.